Gene: XKR9
Official Full Name: XK related 9provided by HGNC
Gene Summary: Predicted to enable phospholipid scramblase activity. Predicted to be involved in apoptotic process involved in development; engulfment of apoptotic cell; and phosphatidylserine exposure on apoptotic cell surface. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12566 | XKR9 Knockout cell line (A549) | Human | XKR9 | 1:3~1:4 | Negative | Online Inquiry |
XKR9 Gene Knockout Cell Lines are genetically modified cells that have had the XKR9 gene selectively disrupted, enabling researchers to study the biological functions and pathways associated with this gene in a controlled environment. The knockout of XKR9 provides a unique model to investigate its role in cellular mechanisms, including apoptosis, cell adhesion, and the immune response. This gene is of particular interest due to its implicated roles in various diseases, including certain cancer pathways and autoimmune disorders.
The primary function of these cell lines lies in their ability to provide insights into how the absence of the XKR9 gene influences cellular behavior, signaling pathways, and gene expression profiles. Researchers can observe the effects of XKR9 knockout on cell proliferation, differentiation, and survival, thereby establishing a clearer understanding of its physiological and pathological roles.
In scientific research, XKR9 Gene Knockout Cell Lines are invaluable tools for exploring gene function and validating therapeutic targets. Their use can significantly aid in drug development processes, allowing scientists to assess the efficacy and safety of new compounds in a setting that mimics disease states more accurately than wild-type cells.
One of the specific advantages of our XKR9 Gene Knockout Cell Lines is that they are thoroughly characterized and validated, ensuring consistency and reliability in research outcomes. Unlike alternative models, these cell lines are readily available and designed for easy integration into existing experimental setups, saving researchers valuable time and resources.
For researchers and clinicians focused on molecular biology, oncology, or immunology, our XKR9 Gene Knockout Cell Lines represent a crucial advancement that can accelerate discoveries and lead to new therapeutic strategies. The precision and reliability they offer make them an essential addition to any laboratory engaged in gene function studies.
Our company prides itself on its strong background in genetic engineering and cell line development, guaranteeing high-quality biological products that address the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.